ES2141725T3 - Derivados de oxazolidinona, utiles como agentes antiarritmicos y antifibriladores. - Google Patents

Derivados de oxazolidinona, utiles como agentes antiarritmicos y antifibriladores.

Info

Publication number
ES2141725T3
ES2141725T3 ES92918216T ES92918216T ES2141725T3 ES 2141725 T3 ES2141725 T3 ES 2141725T3 ES 92918216 T ES92918216 T ES 92918216T ES 92918216 T ES92918216 T ES 92918216T ES 2141725 T3 ES2141725 T3 ES 2141725T3
Authority
ES
Spain
Prior art keywords
ring
substituted
nothing
carboxyl
saturated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92918216T
Other languages
English (en)
Spanish (es)
Inventor
Stanford Salvatore Pelosi Jr
Chia-Nien Yu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Chilcott Pharmaceuticals Inc
Original Assignee
Procter and Gamble Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter and Gamble Pharmaceuticals Inc filed Critical Procter and Gamble Pharmaceuticals Inc
Application granted granted Critical
Publication of ES2141725T3 publication Critical patent/ES2141725T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Furan Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
ES92918216T 1991-08-14 1992-08-10 Derivados de oxazolidinona, utiles como agentes antiarritmicos y antifibriladores. Expired - Lifetime ES2141725T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US74486591A 1991-08-14 1991-08-14

Publications (1)

Publication Number Publication Date
ES2141725T3 true ES2141725T3 (es) 2000-04-01

Family

ID=24994270

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92918216T Expired - Lifetime ES2141725T3 (es) 1991-08-14 1992-08-10 Derivados de oxazolidinona, utiles como agentes antiarritmicos y antifibriladores.

Country Status (23)

Country Link
US (1) US5994354A (cs)
EP (2) EP0599968B1 (cs)
JP (1) JPH06510285A (cs)
AT (1) ATE188696T1 (cs)
AU (1) AU665367B2 (cs)
BR (1) BR9206353A (cs)
CA (1) CA2115029C (cs)
CZ (1) CZ283323B6 (cs)
DE (1) DE69230563T2 (cs)
DK (1) DK0599968T3 (cs)
ES (1) ES2141725T3 (cs)
FI (1) FI940658A7 (cs)
GR (1) GR3032432T3 (cs)
HU (1) HUT70144A (cs)
IL (1) IL102791A (cs)
MX (1) MX9204736A (cs)
NO (1) NO300807B1 (cs)
NZ (1) NZ243936A (cs)
PL (1) PL171280B1 (cs)
PT (1) PT100775B (cs)
RU (1) RU2125568C1 (cs)
SK (1) SK16994A3 (cs)
WO (1) WO1993004064A1 (cs)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2221788C2 (ru) * 1991-08-14 2004-01-20 Проктер энд Гэмбл Фармасьютикалз Оксоциклические соединения мочевины, фармацевтическая композиция, способ лечения
CZ283323B6 (cs) * 1991-08-14 1998-02-18 Procter And Gamble Pharmaceuticals, Inc. Cyklické urethany použitelné jako antiarytmická a antifibrilační činidla a farmaceutické přípravky, které je obsahují
DE69232825D1 (de) * 1991-08-14 2002-11-21 Procter & Gamble Pharma Zyklische Harnstoffe mit antiarrhythmischer und antifibrillatorischer Wirkung
DE69936449T2 (de) 1998-04-29 2008-03-06 The Procter & Gamble Company, Cincinnati Verfahren zur herstellung von 1,3-disubstituierten-4-oxocyclischen harnstoffen
CA2330685A1 (en) 1998-04-29 1999-11-04 The Procter & Gamble Company Process for making 1,3-disubstituted-4-oxocyclic ureas
CN1171610C (zh) * 2002-04-23 2004-10-20 张瑞香 一种治疗心脑血管和眼底病的中药针剂及其制备方法
WO2009042766A1 (en) * 2007-09-26 2009-04-02 Mount Sinai School Of Medicine Azacytidine analogues and uses thereof

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE624402A (cs) *
US2802002A (en) * 1956-07-18 1957-08-06 Norwich Pharma Co Series of new nu-(5-nitro-2-furyl) alkylidene-3-amino-5-tertiaryamino-methyl-2-oxazolidones and the preparation thereof
GB843834A (en) * 1957-05-13 1960-08-10 Norwich Pharma Co N-(5-nitro-2-furyl)-alkylidene-3-amino-5-tertiaryaminomethyl-2-oxazolidones and chemotherapeutic compositions containing them
FR1274399A (fr) * 1958-01-23 1961-10-27 Norwich Pharma Co Procédé perfectionné de préparation de dérivés du 5-nitro-2-formyl-furan
NL104211C (cs) * 1958-02-28
US3004888A (en) * 1959-01-12 1961-10-17 Pfizer & Co C Mastitis treatment
NL266216A (cs) * 1960-07-12
FR385M (fr) * 1960-08-17 1961-03-24 Norwich Pharma Co Nouveau médicament pour le traitement des infections staphylococciques et analogues.
CH398599A (fr) * 1961-03-24 1966-03-15 Om Lab Sa Procédé de préparation d'hydrazones de l'a-bromo-B-(5-nitro-2-furyl)acroléine
BE633841A (cs) * 1962-06-21
BE635608A (cs) * 1962-08-01
US3415821A (en) * 1965-09-07 1968-12-10 Norwich Pharma Co 1-(5-substituted)furfurylideneamino hydantoins and imidazolidinones
US3318878A (en) * 1966-04-14 1967-05-09 Smith Kline French Lab Nitrothiophene compounds
GB1279408A (en) * 1968-09-12 1972-06-28 Ciba Geigy Ag 5-nitro-2-furfurylideneamino-oxazolidinones
US3839567A (en) * 1969-04-17 1974-10-01 Schering Ag Pharmaceutical compositions comprising 3-(5-nitro-2-imidazolyl-methylen-amino)-2-oxazolidinones and their use in trichomoniasia
US3906101A (en) * 1969-06-05 1975-09-16 Ciba Geigy Corp Pharmaceutical compositions containing substituted 5-nitrofurfurylideneamino-oxazolidinones
US4775670A (en) * 1980-09-29 1988-10-04 E. R. Squibb & Sons, Inc. 2-oxo-1-azetidinesulfonic acid salts
US4393204A (en) * 1982-05-21 1983-07-12 Norwich Eaton Pharmaceuticals, Inc. 3-[[5-(4-Chlorophenyl)furfurylidene]amino]-5-(substituted)-2-oxazolidinones
US4466965A (en) * 1982-07-26 1984-08-21 American Hospital Supply Corporation Phthalazine compounds, compositions and use
US4543359A (en) * 1982-10-01 1985-09-24 Eaton Laboratories, Inc. Treating cardiac arrhythmias with dantrolene sodium
US4705799A (en) * 1983-06-07 1987-11-10 E. I. Du Pont De Nemours And Company Aminomethyl oxooxazolidinyl benzenes useful as antibacterial agents
US4581370A (en) * 1983-07-12 1986-04-08 Schering A.G. Antiarrhythmic imidazoliums
US4720580A (en) * 1984-09-21 1988-01-19 American Home Products Corporation N-(aminoalkylene)benzenesulfonamides
US4707499A (en) * 1985-12-02 1987-11-17 G. D. Searle & Co. 3-alkyl-5-(substituted amino)methyl)dihydro-3-phenyl-2(3H)-furanones and imino analogs thereof used for treatment of arrhythmia
PH23283A (en) * 1986-02-26 1989-06-30 Eisai Co Ltd Piperidine derivative, pharmaceutical composition containing the same and method of use thereof
US4713832A (en) * 1986-04-11 1987-12-15 Ampex Corporation Programmable divider up/down counter with anti-aliasing feature and asynchronous read/write
IL79174A0 (en) * 1986-06-05 1986-09-30 Abic Ltd Water soluble salt of furaltadone
US4895867A (en) * 1986-06-26 1990-01-23 Norwich Eaton Pharmaceuticals, Inc. 2-(5-phenyl-2-furanyl)imidazoles useful as cardiotonic agents
AU607735B2 (en) * 1987-05-07 1991-03-14 A.H. Robins Company, Incorporated Novel cyclic carbamate derivatives
US4886794A (en) * 1987-05-07 1989-12-12 A. H. Robins Company, Incorporated 4-[(α,α-diaryl)-hydroxymethyl]-1-piperidinylalkyl-cyclic carbamate derivatives as allergic response inhibitors
US4882354A (en) * 1987-12-16 1989-11-21 Norwich Eaton Pharmaceuticals, Inc. N-hydroxy-5-phenyl-2-furancarboximidamides useful as cardiotonic agents
US4870095A (en) * 1988-06-13 1989-09-26 Sterling Drug, Inc. 1H-pyrazole-1-alkanamides, antiarrhythmic compositions and use
EP0347733A1 (en) * 1988-06-20 1989-12-27 Eisai Co., Ltd. Optically active hydantoin derivatives
US4948801A (en) * 1988-07-29 1990-08-14 E. I. Du Pont De Nemours And Company Aminomethyloxooxazolidinyl arylbenzene derivatives useful as antibacterial agents
AU617871B2 (en) * 1988-09-15 1991-12-05 Pharmacia & Upjohn Company In position 3 substituted-5-beta-amidomethyl-oxazolidin-2- ones
PH30434A (en) * 1989-04-07 1997-05-09 Janssen Pharmaceutica Nv Hydroxyalkylfuranyl derivatives
US5091426A (en) * 1989-06-23 1992-02-25 Norwich Eaton Pharmaceuticals, Inc. 5-phenyl-2-furan ketones and use as antiepileptic agents
US4966967A (en) * 1989-09-15 1990-10-30 Berlex Laboratories, Inc. 3,4,5,6-tetrahydro-2H-1,7,4-benzodioxazonines as cardiovascular agents
US5032598A (en) * 1989-12-08 1991-07-16 Merck & Co., Inc. Nitrogens containing heterocyclic compounds as class III antiarrhythmic agents
US4963561A (en) * 1990-02-28 1990-10-16 Sterling Drug Inc. Imidazopyridines, their preparation and use
US5066662A (en) * 1990-05-21 1991-11-19 Warner-Lambert Company Substituted oxazolidin-2-ones and 1,2,4-oxadiazolin-5-ones and derivatives thereof acting at muscarinic receptors
US5086055A (en) * 1990-12-24 1992-02-04 A. H. Robins Company, Incorporated Series of 5-[-(4-aryl-1-piperazinyl)alkyl]-2-oxazolidinone derivatives useful in the treatment of allergic conditions
FR2675504B1 (fr) * 1991-04-16 1995-01-27 Delalande Sa Derives d'aryl-3 oxazolidinone, leur procede de preparation et leur application en therapeutique.
CZ283323B6 (cs) * 1991-08-14 1998-02-18 Procter And Gamble Pharmaceuticals, Inc. Cyklické urethany použitelné jako antiarytmická a antifibrilační činidla a farmaceutické přípravky, které je obsahují

Also Published As

Publication number Publication date
CZ27894A3 (en) 1995-07-12
GR3032432T3 (en) 2000-05-31
IL102791A0 (en) 1993-01-31
FI940658A0 (fi) 1994-02-11
RU2125568C1 (ru) 1999-01-27
DK0599968T3 (da) 2000-04-17
CA2115029C (en) 2002-03-26
ATE188696T1 (de) 2000-01-15
EP0957103A1 (en) 1999-11-17
MX9204736A (es) 1993-11-01
CA2115029A1 (en) 1993-03-04
IL102791A (en) 1998-06-15
NZ243936A (en) 1996-10-28
CZ283323B6 (cs) 1998-02-18
HU9400403D0 (en) 1994-05-30
EP0599968B1 (en) 2000-01-12
SK16994A3 (en) 1995-03-08
WO1993004064A1 (en) 1993-03-04
FI940658A7 (fi) 1994-02-11
HUT70144A (en) 1995-09-28
BR9206353A (pt) 1995-11-07
DE69230563T2 (de) 2000-09-14
AU665367B2 (en) 1996-01-04
PT100775A (pt) 1994-01-31
DE69230563D1 (de) 2000-02-17
NO300807B1 (no) 1997-07-28
PL171280B1 (pl) 1997-03-28
PT100775B (pt) 1999-09-30
EP0599968A1 (en) 1994-06-08
AU2467892A (en) 1993-03-16
US5994354A (en) 1999-11-30
NO940496L (no) 1994-02-14
JPH06510285A (ja) 1994-11-17
NO940496D0 (no) 1994-02-14

Similar Documents

Publication Publication Date Title
UY23635A1 (es) Procedimiento para la preparacion de conjugados del peg interferon
ES2141725T3 (es) Derivados de oxazolidinona, utiles como agentes antiarritmicos y antifibriladores.
ES2083773T3 (es) Derivados de 1,3-dihidro-2h-imidazo(4,5-b)quinolin-2-ona como inhibidores de fosfodiesterasa.
ES2169086T3 (es) Isoxazolinas sustituidas, procedimiento para su preparacion, agentes que las contienen y su utilizacion como antidotos.
AR033383A1 (es) Derivados de acridina, procedimiento para prepararlos, el uso de los mismos para la preparacion de medicamentos y los medicamentos que contienen dichos derivados
LU90155I2 (fr) Vistide - cidofovir 75 mg/ml
ES2132351T3 (es) Compuestos con un grupo sulfamoilo y amidino, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ES2146213T3 (es) Compuestos de porficeno para terapia fotodinamica.
ES2065133T3 (es) Derivados de piperazina.
CO6170405A2 (es) Composicion plaguicida que comprende fluopicolida y un compuesto insecticida
ES2191412T3 (es) Derivados de aminoacidos que contienen fluor.
ES478717A1 (es) Procedimiento para la obtencion de lipopetidos.
ES8507534A1 (es) Procedimiento para la preparacion de derivados benzopiranicos
ES2118333T3 (es) Derivados del acido naftilacetico como agonistas y antagonistas de pgez.
ES2146784T3 (es) Composiciones de peracido espesadas.
MX9504381A (es) Derivados de ureido de acidos naftalenfosfonicos y procesos para su preparacion.
ES2123831T3 (es) Micofenolato de mofetilo cristalino anhidro y formulacion intravenosa del mismo.
ES2068908T3 (es) Compuestos de poliaza macrociclicos que contienen anillos de 5 o 6 eslabones, procedimiento para su preparacion y agentes farmaceuticos que los contienen.
ECSP045373A (es) Sales de tolterodina
ES2121003T3 (es) Nuevos derivados del acido metilenbisfosfonico.
ES2180537T3 (es) Nuevas ureas 4-oxociclicas, utilizables como agentes antiarritmicos o antifibrilantes.
ES2063039T3 (es) Derivados de imidazo(1,2-b)piridazina.
ES2029879T3 (es) Procedimiento para producir derivados de aminas sustituidas.
ES2117132T3 (es) Sales de desferrioxamina-b y su uso como queladores de hierro eficaces por via oral.
ES2109988T3 (es) Derivados cefalosporinicos.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 599968

Country of ref document: ES